ABSTRACT NUMBER: ESOC2026LT42 LT42 - SAFETY AND EFFICACY OF INTRA-ARTERIAL TENECTEPLASEFOR NON-COMPLETE REPERFUSION OF INTRACRANIALOCCLUSIONS (TECNO)
Johannes Kaesmacher, Adnan Mujanovic, Lukas Bütikofer, Seraina Beyeler, Morin Beyeler, Tomas Dobrocky, Eike Piechowiak, Jan Gralla, Urs Fischer · 2026
Read ABSTRACT NUMBER: ESOC2026LT42 LT42 - SAFETY AND EFFICACY OF INTRA-ARTERIAL TENECTEPLASEFOR NON-COMPLETE REPERFUSION OF INTRACRANIALOCCLUSIONS (TECNO) by Johannes Kaesmacher, Adnan Mujanovic, Lukas Bütikofer, Seraina Beyeler, Morin Beyeler, Tomas Dobrocky, Eike Piechowiak, Jan Gralla, Urs Fischer (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13145217.txt.
Description
Johannes Kaesmacher and co-authors lay out a trial of a clot-dissolving drug for stroke care in a 2026 conference abstract. After a device pulls a clot from a brain artery, blood flow often stays incomplete, and those patients fare worse. The TECNO trial asks whether giving the drug tenecteplase into the artery can clear what the device left behind.
The trial, run across many centers, assigned about one hundred sixty patients by chance to the drug or to best medical care alone. Main checks were better flow soon after treatment and clean scans a day later, plus a safety check for bleeding in the brain. The abstract reports the design and enrollment; the main results were set to be shown at the conference. The findings should tell whether the added drug step helps.
Catalog record
| CREATOR | Johannes Kaesmacher, Adnan Mujanovic, Lukas Bütikofer, Seraina Beyeler, Morin Beyeler, Tomas Dobrocky, Eike Piechowiak, Jan Gralla, Urs Fischer |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |